[com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=851]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=850]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=849]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=848]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=847]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=846]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=845]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=844]], com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=843]]][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88749]], camposKey:1664-042X 2024-01-01 A sex-dependent role of Kv1.3 channels from macrophages in metabolic syndrome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76178]], camposKey:0753-3322 2023-05-01 Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76179]], camposKey:0753-3322 2023-02-01 Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74170]], camposKey:0021-9541 2023-01-01 Characterization of endogenous Kv1.3 channel isoforms in T cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76180]], camposKey:0194-911X 2023-01-01 Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension8496, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58959]], camposKey:0007-1188 2021-04-01 KV1.3 channels are novel determinants of macrophage-dependent endothelial dysfunction in angiotensin II-induced hypertension in mice18361854, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58961]], camposKey:1661-6596 2021-02-01 Kv1.5¿kvß1.3 recycling is pkc-dependent112, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58960]], camposKey:1661-6596 2021-02-01 Pharmacological approaches for the modulation of the potassium channel kv4.X and KChIPs121, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=67094]], camposKey:2701-0198 2021-01-01 Graphene Particles Interfere with Pro-Inflammatory Polarization of Human Macrophages: Functional and Electrophysiological Evidence21008820, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58962]], camposKey:0007-1188 2021-01-01 Identification of a critical binding site for local anaesthetics in the side pockets of Kv1 channels00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58963]], camposKey:1662-5099 2019-02-12 Identification of IQM-266, a novel DREAM ligand that modulates KV4 currents00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=67093]], camposKey:2045-2322 2019-01-01 Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington's disease treatment00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58964]], camposKey:0022-2828 2017-09-01 D242N, a KV7.1 LQTS mutation uncovers a key residue for IKs voltage dependence6169, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=67092]], camposKey:1663-9812 2017-01-01 Fludarabine Inhibits KV1.3 Currents in Human B Lymphocytes00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58965]], camposKey:2325-8861 2017-01-01 IKs computational modeling to enforce the investigation of D242N, a KV7.1 LQTS mutation14, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58966]], camposKey:0007-1188 2014-01-01 PKC inhibition results in a Kv1.5 + Kvß1.3 pharmacology closer to Kv1.5 channels49144926][][][][com.sigma.fs3.argos.domain.gpc.AltresActivPers[id=com.sigma.fs3.argos.domain.gpc.GpcAltresActivPersPK[ifcactivitat=AAP, ifccomptador=842]]][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63891]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63891]]][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@712e364c, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2e9ff39a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5d0d3504, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7ec559b9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7ed99c7b, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2f8ba319, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1b9a06f9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4fc69ca2, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7dceeb65, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@faf1cae, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@44c96e6c][][][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5b8ee5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c0d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f309]][][][][][][][]
